Patent ID: 8741837
Filing Date: 2014-06-03
Classification: A61K,A61P,C07K,C12N

Abstract:
1. A method for inhibiting HCV protease, or a mutant thereof, in a patient comprising the step of administering to a patient in need thereof a compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: R R R each R is independently hydrogen, optionally substituted C R R 4 is H, —NHC(O)R 5 , —NHC(O)OR 6 ,  or a natural or unnatural amino acid side-chain group; each R R R R  or R each occurrence of R R m is an integer from 0 to 4, inclusive; s is an integer from 0 to 4, inclusive; t is an integer from 0 to 4, inclusive; wherein the sum of s and t is non-zero.